CDKN2C Antikörper
Kurzübersicht für CDKN2C Antikörper (ABIN306017)
Target
Alle CDKN2C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- For optimum results, immunoprecipitate with Western blot Species cross-reactivity: human, mouse.
-
Aufreinigung
- Protein G purified
-
Immunogen
- Purified recombinant p18INK4c protein.
-
Isotyp
- IgG1
-
-
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) antibody
CDKN2C Reaktivität: Human, Maus, Ratte IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) antibodyCDKN2C Reaktivität: Human WB, IF Wirt: Kaninchen Monoclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) (AA 113-139), (C-Term) antibodyCDKN2C Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB20696 unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) (AA 1-168) antibodyCDKN2C Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) (AA 1-68) antibodyCDKN2C Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) (AA 111-160) antibodyCDKN2C Reaktivität: Human, Maus WB, IHC, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) (AA 113-139) antibodyCDKN2C Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) (C-Term) antibodyCDKN2C Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) antibodyCDKN2C Reaktivität: Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C) antibodyCDKN2C Reaktivität: Human WB Wirt: Maus Monoclonal 2E1 unconjugated
-
-
Applikationshinweise
-
Approved: IF, IHC, IHC-P, IP, WB
Usage: Immunofluorescence. Immunoprecipitation (Co-precipitates cdk4) (Use Protein G) (Ab 1-2 μg/mg protein lysate). Western Blot (Ab 1-2 μg/mL for 2hrs at RT). Immunohistochemistry (Formalin/paraffin) (Use Ab at 2-4 μg/mL for 30 min at RT) ** (Staining of formalin/paraffin tissues is requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min.). Positive control: HeLa cells. Tonsil. The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 10 mM PBS, pH 7.4.
-
Konservierungsmittel
- Azide free
-
-
- CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))
-
Andere Bezeichnung
- CDKN2C / p18 INK4c
-
Hintergrund
-
Name/Gene ID: CDKN2C
Synonyms: CDKN2C, CDK6 inhibitor p18, CDKN6, Cyclin-dependent inhibitor, p18 INK4c, p18-INK6, INK4C, p18, p18-INK4C -
Gen-ID
- 1031
-
UniProt
- P42773
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-
